DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE manufacturers
|
| | DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE Basic information |
| Product Name: | DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE | | Synonyms: | DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE;5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3-[(2-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-1-benzopyrylium chloride;Delphinidin 3-sambubioside chloride;DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE(RG);delphinidin 3-O-beta-D-sambubioside;Delphinidin 3-Sambubioside;DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE USP/EP/BP;delphinidin 3-O-β-D-sambubioside | | CAS: | 53158-73-9 | | MF: | C26H29O16.Cl | | MW: | 632.95 | | EINECS: | | | Product Categories: | | | Mol File: | 53158-73-9.mol |  |
| | DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE Chemical Properties |
| storage temp. | -20°C | | solubility | Soluble in methan | | form | powder | | color | Dark, reddish | | Major Application | food and beverages | | SMILES | OC1=CC(O)=C(C=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)C(C4=CC(O)=C(O)C(O)=C4)=[O+]5)C5=C1.[Cl-] |
| WGK Germany | WGK 3 | | Storage Class | 13 - Non Combustible Solids |
| | DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE Usage And Synthesis |
| Uses | Delphinidin 3-sambubioside chloride may be used as an analytical standard for the determination of the analyte in calyces of Hibiscus sabdariffa flowers by high performance liquid chromatography (HPLC) technique. | | Definition | ChEBI: An anthocyanidin 3-O-beta-D-sambubioside having delphinidin as the anthocyanidin component. | | General Description | This substance is supplied with certified chromatographic purity. The exact value can be found on the certificate. Produced by PhytoLab GmbH & Co. KG | | in vivo | Delphinidin-3-sambubioside chloride (15 μmol/kg, i.p.) inhibits mouse paw edema induced by LPS[1].
Delphinidin-3-sambubioside chloride (30 mg/kg body, oral gavage, daily for eight weeks) decreases lipid accumulation in HFD rats[3].
| Animal Model: | Delphinidin-3-sambubioside chloride (15 μmol/kg, i.p.) Inhibit LPS-induced paw edema in mice[1].
Delphinidin-3-sambubioside chloride (30 mg/kg body，Gavage once daily for eight weeks to reduce lipid accumulation in HFD rats[3]。
| | Dosage: | 15 μmol/kg | | Administration: | Intraperitoneal injection (i.p.), for 4 days. | | Result: | Reduced the LPS-induced paw thickness.
Decreased the edema by 89.3%.
Decreased the levels of LPS induced serum IL-6, MCP-1 and TNF-α. |
| Animal Model: | HFD-fed rats[3] | | Dosage: | 30 mg/kg | | Administration: | Oral gavage, daily for eight weeks. | | Result: | Reduced the body weight gain, visceral fat, and abdominal fat and decreased hepatic lipid deposits. |
| | target | ROS |
| | DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE Preparation Products And Raw materials |
|